|
Originally published In Press as doi:10.1074/jbc.R200006200 on June 26, 2002
J. Biol. Chem., Vol. 277, Issue 34, 30409-30412, August 23, 2002
MINIREVIEW
The Key Role of Anaplerosis and Cataplerosis for Citric
Acid Cycle Function*
Oliver E.
Owen ,
Satish C.
Kalhan, and
Richard W.
Hanson
From the Departments of Pediatrics and Biochemistry, Case Western
Reserve University School of Medicine, Robert Schwartz M.D. Center for
Metabolism and Nutrition, MetroHealth Medical Center,
Cleveland, Ohio 44109
 |
INTRODUCTION |
The oxidation of acetyl-CoA to CO2
by the TCA1 cycle is the
central process in energy metabolism. However, the TCA cycle also functions in biosynthetic pathways in which intermediates leave the
cycle to be converted primarily to glucose, fatty acids, or non-essential amino acids. If TCA cycle anions are removed from the
cycle they must be replaced to permit its continued function. This
process is termed anaplerosis. Pyruvate carboxylase, which generates oxalacetate directly in the mitochondria, is the major anaplerotic enzyme. Conversely, 4- and 5-carbon intermediates enter the
TCA cycle during the catabolism of amino acids. Because the TCA cycle
cannot fully oxidize 4- and 5-carbon compounds, these intermediates
must be removed from the cycle by a process termed
cataplerosis. Cataplerosis may be linked to biosynthetic processes such as gluconeogenesis in the liver and kidney cortex, fatty
acid synthesis in the liver, and glyceroneogenesis in adipose tissue.
Cataplerotic enzymes present in many mammalian tissues include
P-enolpyruvate carboxykinase (PEPCK), glutamate dehydrogenase, aspartate aminotransferase, and citrate lyase. In this review we have
evaluated the roles of anaplerosis and cataplerosis in whole body metabolism.
 |
Biochemical Role of Anaplerosis and Cataplerosis in Function
of TCA |
The expression anaplerotic sequences was a term used in
biochemistry by Sir Hans Kornberg (1) to describe a series of enzymatic reactions or pathways that replenish the pools of metabolic
intermediates in the TCA cycle. These intermediates are critical for
the functioning of the TCA cycle, the primary role of which is the
oxidation of acetyl-CoA to carbon dioxide. The pool of TCA cycle
intermediates is sufficient to sustain the oxidative carbon flux over a
fairly wide range, so that during high energy consumption
(e.g. exercise) or during lower energy consumption
(e.g. fasting), there is not a large change in the pool size
of TCA intermediates (2). However, in several physiological states,
there is a large influx (anaplerosis) of 4- and 5-carbon intermediates
into the TCA cycle. Because the TCA cycle cannot act as a carbon sink,
anaplerosis must be coupled with the exit of intermediates from the
cycle via cataplerosis. The importance of anaplerotic reactions for
cellular metabolism is thus apparent. However, the coupling of this
process with cataplerosis and the roles that both pathways play in the
regulation of amino acid, glucose, and fatty acid metabolism
have not been emphasized to a sufficient extent.
The terms anaplerosis and cataplerosis describe reciprocal and
correlative reactions involved in the function of the TCA cycle. The
enzymatic steps in these processes have long been known, but the
overall concept of a linkage between anaplerosis and cataplerosis should be underscored, because the balance between these two processes controls the entry and exit of TCA cycle anions. Anaplerotic and cataplerotic reactions are involved in the ultimate disposal of all
metabolic intermediates. The metabolic role of anaplerosis and
cataplerosis in amino acid metabolism varies with specific organs and
is dependent on the nutritional/metabolic status of the individual.
During feeding, the intestine is an important site of catabolism of
enterally derived amino acids, whereas in the starved state amino acid
catabolism occurs primarily in the kidney, liver, and muscle.
The catabolism of amino acids produces gluconeogenic or ketogenic
precursors (Table I). The disposal of
gluconeogenic anions in the TCA cycle employs anaplerotic and
cataplerotic pathways for their terminal oxidation. The only known
pathway for the terminal oxidation of leucine is through acetoacetate
to acetyl-CoA and subsequent oxidation in the TCA cycle. However, other
amino acids also have for their disposal alternate ketogenic pathways
for terminal oxidation. Thus, the ketogenic amino acids from
proteolysis can be terminally oxidized in muscle, whereas the
gluconeogenic amino acids are dependent upon anaplerosis and
cataplerosis for conversion to glucose in the liver and kidney before
oxidation to CO2 and H2O.
View this table:
[in this window]
[in a new window]
|
Table I
Metabolic fates of amino acids in the TCA cycle
Pyruvate can enter the TCA cycle after being carboxylated to
oxaloacetate via pyruvate carboxylase (anaplerosis). Malate synthesized
from the oxaloacetate exits the TCA cycle for gluconeogenesis. Pyruvate
may also be decarboxylated to acetyl-CoA by pyruvate dehydrogenase
complex and the acetyl-CoA then fully oxidized to CO2 in the
TCA cycle.
|
|
Anaplerosis--
The first reaction of the TCA cycle, citrate
synthase, catalyzes the condensation of oxalacetate with acetyl-CoA;
the oxalacetate is subsequently regenerated by the reactions of the
cycle and condenses with another molecule of acetyl-CoA. However, the
TCA cycle also functions in biosynthetic processes in which
intermediates are removed from the cycle; this necessitates anaplerotic
reactions to replenish TCA cycle intermediates to ensure its continued
function. Pyruvate carboxylase, which synthesizes oxalacetate from
pyruvate in the mitochondrial matrix, is the archetypical anaplerotic
enzyme. The activity of this enzyme is high in many tissues
(e.g. 10-12 units/g of liver); acetyl-CoA is a positive
allosteric regulator of the enzyme. Anaplerosis is obligatory during
both gluconeogenesis and lipogenesis when malate (gluconeogenesis) or
citrate (lipogenesis) leaves the mitochondria and is further
metabolized to form glucose or fatty acids, respectively.
Cataplerosis--
If intermediates can be added to the TCA cycle,
it is equally important to remove them to avoid the accumulation of
anions in the mitochondrial matrix. Cataplerosis describes reactions involved in the disposal of TCA cycle intermediates. There are several
cataplerotic enzymes; these include PEPCK, aspartate aminotransferase, and glutamate dehydrogenase. Each of these reactions has as substrate a
TCA cycle anion that is converted to a product that effectively removes
intermediates from the cycle. In the liver and kidney, the role of
PEPCK in cataplerosis is of special importance because it is a common
route for the generation of PEP from oxalacetate to be used for
gluconeogenesis. Alternatively, in muscle, PEP can be converted to
pyruvate that can be decarboxylated to acetyl-CoA for subsequent
oxidation to CO2 in the TCA cycle.
The regulation of anaplerosis and cataplerosis depends upon the
metabolic and physiologic state and the specific tissue/organ involved.
For example, during starvation, cataplerosis via phosphoenolpyruvate to
support gluconeogenesis may be regulatory in the liver, whereas in the
kidney anaplerosis via uptake of glutamine may be regulatory. Anaplerotic and cataplerotic intermediates entering and exiting the TCA
cycle are shown in Fig. 1. A detailed and
elegant analysis of amino acid metabolism can be found in a review by
Jungas et al. (3).

View larger version (20K):
[in this window]
[in a new window]
|
Fig. 1.
Anaplerosis and cataplerosis in the TCA
cycle. The TCA cycle is presented with the major anaplerotic and
cataplerotic reactions illustrated. These include the net entry of
amino acids into the cycle and the generation of oxaloacetate from
pyruvate via pyruvate carboxylase. The cataplerotic reactions in the
figure illustrate the linkage of this process to both gluconeogenesis
and lipogenesis.
|
|
 |
Physiological Role of Cataplerosis and Anaplerosis in Metabolism
of Glutamine in Human Kidney |
The interplay between anaplerotic and cataplerotic reactions in
humans was demonstrated by renal metabolism during total, prolonged
starvation (4). Arteriovenous concentration differences of metabolites
across the kidneys coupled with urinary nitrogen losses showed that the
kidney extracted glutamine and produced urinary ammonium (5).
Concurrently, the kidney released glucose into the blood. It was
initially recognized that renal ammoniagenesis was related to ketonuria
during prolonged starvation when there is an increase in ketogenesis
(6). However, it was not generally appreciated that the entry
(anaplerosis) and removal (cataplerosis) of intermediates into and out
of the TCA cycle as related to renal ammoniagenesis and gluconeogenesis
had to be balanced. This fundamental principle is poorly understood and
is the foundation of this paper.
During prolonged starvation glutamine is transported from muscle to the
kidney where the amino and amide groups are used for ammonia formation.
The ammonia released from the renal cells serves to titrate the acidity
of the tubular urine created by the disassociation of organic acids,
primarily -hydroxybutyric and acetoacetic acids. For ammonia
generation to continue, glutamine undergoes anaplerotic reactions to
form -ketoglutarate that enters the TCA cycle and is sequentially
converted to malate that leaves the mitochondria. Malate is oxidized in
the cytosol to oxalacetate that is subsequently converted to PEP and
then to glucose. Thus, anaplerotic and cataplerotic reactions are
essential and balanced during renal ammoniagenesis and gluconeogenesis.
The heightened ketonuria that occurs with ketonemia is related to the
need for the kidney to generate glucose during total starvation when
renal gluconeogenesis accounts for about 50% of the net glucose
synthesis (4, 7). Thus, renal ammoniagenesis and gluconeogenesis
are tightly interlocked and dependent upon balanced anaplerotic
reactions to replenish the -ketoglutarate in the TCA cycle and
cataplerotic reactions to drain remnant 4-carbon metabolic
intermediates from the cycle to synthesize glucose (7). In addition,
there is a metabolic bonus when the kidneys excrete urinary ammonium
during starvation. The caloric value of protein is greater when amino
acid nitrogen is lost in the urine as ammonium rather than urea because
it requires four molecules of ATP to generate a molecule of urea via
the urea cycle. In addition, energy is required for the synthesis of
creatine and uric acid.
 |
Physiological Role of Anaplerosis and Cataplerosis in Amino
Acid Metabolism in Human Skeletal Muscle |
Despite the relatively slow rate of turnover of skeletal muscle
protein, it represents the largest reservoir of amino acids because of
its large mass. Following an overnight fast, there is a net release of
amino acids from skeletal muscle; however, the amino acids released do
not reflect the amino acid composition of the skeletal muscle proteins
(3, 8). This suggests that there is local metabolism and
interconversion of amino acids in the muscle. Specifically, alanine and
glutamine represent a disproportionately larger fraction of amino acids
released by the skeletal muscle when compared with the amino acid
composition of skeletal muscle proteins. The relative proportion of
these amino acids released by muscle also changes with the metabolic
status, such as prolonged starvation or diabetes, or in response to
administration of insulin or glucagon (3, 8-11). These data suggest
that a local metabolism of amino acids occurs in the skeletal muscle
that results in the de novo synthesis of certain
non-essential amino acids, primarily alanine and glutamine.
Arteriovenous concentration differences across skeleton muscles show
net uptake and/or release of lactate, ammonia, alanine, glutamine, and
glutamate at rest and during exercise (11). In addition, during
exercise there is an increase in the TCA cycle intermediates;
however, the increase in concentration is not equal in all the TCA
intermediates (Table II).
View this table:
[in this window]
[in a new window]
|
Table II
Intramuscular concentrations of individual TCA cycle intermediates at
rest and during exercise
Values are mean ± S.E. in mmol/kg, dry weight; n = 6. Credit for this table should be given to Gibala et al.
(11).
|
|
During caloric restriction, amino acids also provide a source of
energy. Amino acids yield part of their energy during oxidative deamination, but their carbon skeleton must undergo subsequent catabolism to be fully metabolized. Although most amino acids enter the
TCA cycle as 4- or 5-carbon compounds, only acetyl-CoA produced from
their catabolism can be fully oxidized in the cycle. Recent data from
studies in humans have shown that only a small increase in the
concentration of TCA intermediates (mostly 4-carbon) occurs during
fasting or exercise, thus confirming the concept that only small
changes in the amounts of these intermediates are required to adapt to
the need for energy (12, 13).
The removal (cataplerosis) of TCA cycle anions generated from the entry
of amino acids occurs via the action of PEPCK, glutamate dehydrogenase,
or aspartate aminotransferase. Alanine and glutamine are synthesized
from other amino acids and released into the circulation. Alanine is
generated by the transamination of pyruvate via alanine aminotransferase. The possible sources of pyruvate are glucose and
lactate, or PEP via PEPCK, using as a substrate the oxalacetate generated in the TCA cycle (cataplerosis) (13).
The carbon skeleton for the synthesis of glutamine can be generated
from the TCA cycle intermediates formed by the catabolism of
gluconeogenic amino acids such as aspartate and asparagine (14). These
amino acids are capable of generating intermediates that can be
converted by forward flow of the TCA cycle to the -ketoglutarate
required for glutamate synthesis. Transamination of -ketoglutarate,
using the branched-chain amino acids as the source of the amino groups,
accounts for the synthesis of glutamate, which is then converted to
glutamine by glutamine synthase using ammonia generated in muscle by
the purine nucleotide cycle. In light of the concept of balanced
anaplerosis and cataplerosis, branched-chain amino acid metabolism in
muscle needs to be studied further.
 |
Physiological Role of Anaplerosis and Cataplerosis in
Metabolism of Glutamine by Human Small Intestine |
Another paradigm for the metabolic roles of anaplerosis and
cataplerosis is the oxidation of glutamine to CO2 in the
small intestine. In this case, the -ketoglutarate formed from
glutamine is converted to malate by the TCA cycle; the malate leaves
the mitochondria and is oxidized in the cytosol to oxalacetate by NAD:malate dehydrogenase. The oxalacetate is decarboxylated to PEP by
PEPCK, and the PEP is converted to pyruvate by pyruvate kinase. The
pyruvate re-enters the mitochondria where it is decarboxylated to
acetyl-CoA by the pyruvate dehydrogenase complex; the acetyl-CoA is
then oxidized by the TCA cycle. Alternately, a fraction of the pyruvate
may be transaminated to alanine in the cytosol (Fig. 2).

View larger version (20K):
[in this window]
[in a new window]
|
Fig. 2.
The role of anaplerosis and cataplerosis in
the metabolism of glutamine by the small intestine. The small
intestine metabolizes glutamine for energy via the TCA cycle. The entry
of glutamine into the cycle (anaplerosis) is balanced by its removal
(cataplerosis) as malate. The malate is subsequently converted to
oxaloacetate (OAA) and then to PEP via PEPCK. The PEP can
then be converted to pyruvate by pyruvate kinase for entry into the TCA
cycle as acetyl-CoA. In addition, pyruvate may be transaminated to
alanine.
|
|
Recent research on the metabolism of glutamine in human adults and
infants illustrates the critical role of anaplerosis and cataplerosis
in amino acid metabolism in the gut. In normal healthy adults, almost
74% of the enterally administered glutamine was extracted by the
splanchnic compartment during the first pass (15), whereas 70-80% of
enterally administered [13C]glutamine tracer was found in
respiratory CO2 (16). Other data from studies of newborn
infants also show that enterally administered glutamine is rapidly
metabolized in the gut as an energy source for the enterocytes,
resulting in increased urea production (17). The majority of the
glutamine is metabolized by the small intestine and not the liver,
because there is no observed dilution of parenterally administered
[15N]glutamine. This suggests that the carbon skeleton of
dietary glutamine is oxidized by the small intestine (not the liver) as a source of energy.
The metabolism of glutamine by the small intestine illustrates the
importance of both anaplerosis and cataplerosis in the metabolism of
the 5-carbon intermediates formed from the catabolism of the carbon
skeletons of amino acids. For the carbon skeleton of glutamine to be
metabolized to CO2 in the TCA cycle, the -ketoglutarate formed from glutamate (originally from the deamination of glutamine) must be converted to acetyl-CoA for full oxidation. As shown in Fig. 2,
the removal of carbon from the TCA cycle involves the cataplerotic
activity of PEPCK in the small intestine, which synthesizes PEP from
the oxalacetate generated from the oxidation of -ketoglutarate.
 |
Role of Cataplerosis in Synthesis of Triglyceride
(Glyceroneogenesis) in Adipose Tissue during Fasting |
The synthesis of triglyceride in adipose tissue during
starvation is another example of cataplerosis linked to a biosynthetic pathway. There is a net breakdown of triglyceride in adipose tissue during fasting (lipolysis) that is stimulated by cAMP and inhibited by
insulin. During starvation when the rates of lipolysis are highest, a
major fraction (up to 30%) of the free fatty acids generated
from triglyceride breakdown is re-esterified back to triglyceride in
adipose tissue (18-21). This process requires a source of 3-glycerol
phosphate, which is generally supplied by glucose via glycolysis.
However, during prolonged starvation glucose utilization by adipose
tissue is curtailed to spare glucose as a fuel for the brain and red
blood cells. An alternative source of 3-glycerol phosphate is provided
by glyceroneogenesis, an abbreviated version of
gluconeogenesis, which provides the glyceride glycerol in
triglyceride in adipose tissue (Fig.
3) (22, 23). Rats fed a high protein,
carbohydrate-free diet synthesize up to 80% of their glyceride
glycerol in white adipose tissue by glyceroneogenesis (24).

View larger version (16K):
[in this window]
[in a new window]
|
Fig. 3.
Linkage of anaplerosis, cataplerosis, and
glyceroneogenesis in adipose tissue. The pathway of
glyceroneogenesis from pyruvate is illustrated to stress the balance of
anaplerosis (the entry of oxaloacetate (OAA) synthesized
from pyruvate via pyruvate carboxylase) and cataplerosis (the
removal of intermediates to support the synthesis of
glyceride-glycerol). FA, fatty acid; DHAP,
dihydroxyacetone phosphate.
|
|
Glyceroneogenesis is also an important pathway for the synthesis
of hepatic triglyceride during fasting. It has been estimated that
~50% of the fatty acids taken up by the liver during fasting is
converted to triglyceride and released as very low density lipoproteins (7). Glyceroneogenesis is a major pathway for the
synthesis of the 3-glycerol phosphate that is required to support
triglyceride synthesis in the liver. Studies by Botion et
al. (24) have established that glyceroneogenesis in the livers of
rats fed a high protein, carbohydrate-free diet contributes 80% of the
glyceride glycerol in circulating very low density lipoproteins. In
humans who have fasted for 18 h, 25-60% of the glyceride
glycerol is derived from glyceroneogenesis and only 5% from plasma
glycerol (25).
 |
Conclusions |
The TCA cycle is delicately balanced between the inflow and output
of intermediates for various metabolic processes. The widely held view
of the TCA cycle as a "metabolic furnace" needs modification in
light of information supporting its role in biosynthesis. The cycle
acts more as a traffic circle on a busy highway in which the flow of
cars into the circle must be balanced by the flow out or the entire
traffic pattern will be interrupted with disastrous consequences. In
this essay we have reviewed several metabolic situations in which the
two key processes, anaplerosis and cataplerosis, work together to
ensure the appropriate balance of carbon flow into and out of the TCA
cycle. The beauty of this fundamental biological mechanism is
undeniable in its simplicity and ponderous in its complexity. It is
perhaps as Edmund said in King Lear:
Thou hast spoken right, `tis true.
The wheel is come full circle.
 |
ACKNOWLEDGEMENTS |
We are indebted to Joyce Nolan and Paula Owen
for assistance in the preparation of the manuscript.
 |
FOOTNOTES |
*
This minireview will be reprinted
in the 2002 Minireview Compendium, which
will be available in December, 2002. This work was supported by Grants DK-58620 (to
R. W. H.) and HD11089 (to S. C. K.) from the National Institutes of Health.
To whom correspondence should be addressed: 1401 Spring Mill Rd.,
Gladwyne, PA 19035. Tel.: 610-527-3045; Fax: 610-527-3054; E-mail:
oeowen@comcast.net.
Published, JBC Papers in Press, June 26, 2002, DOI 10.1074/jbc.R200006200
 |
ABBREVIATIONS |
The abbreviations used are:
TCA, tricarboxylic
acid cycle;
PEPCK, phosphoenolpyruvate carboxykinase;
PEP, phosphoenolpyruvate.
 |
REFERENCES |
| 1.
|
Kornberg, H. L.
(1966)
Essays Biochem.
2,
1-31
|
| 2.
|
Graham, T. E.,
and Gibala, M. J.
(1998)
in
Skeletal Muscle Metabolism in Exercise and Diabetes
(Richter, E. A.
, Galbo, H.
, Kiens, B.
, and Saltin, B., eds)
, pp. 271-286, Plenum Press, New York
|
| 3.
|
Jungas, R. L.,
Halperin, M. L.,
and Brosnan, J. T.
(1992)
Physiol. Rev.
72,
419-448[Abstract/Free Full Text]
|
| 4.
|
Owen, O. E.,
Felig, P.,
Morgan, A. P.,
Wahren, J.,
and Cahill, G. F., Jr.
(1969)
J. Clin. Invest.
48,
584-594[Medline]
[Order article via Infotrieve]
|
| 5.
|
Van Slyke, D. D.,
Phillips, R. A.,
Hamilton, P. B.,
Archibald, R. M.,
Futcher, P. H.,
and Hiller, A.
(1943)
J. Biol. Chem.
150,
481-482[Free Full Text]
|
| 6.
|
Sapir, D. G.,
Owen, O. E.,
Cheng, J. T.,
Ginsberg, R.,
Boden, G.,
and Walker, W. G.
(1972)
J. Clin. Invest.
51,
2093-2102[Medline]
[Order article via Infotrieve]
|
| 7.
|
Owen, O. E.,
Smalley, K. J.,
D'Alessio, D. A.,
Mozzoli, M. A.,
and Dawson, E. K.
(1998)
Am. J. Clin. Nutr.
68,
12-34[Abstract]
|
| 8.
|
Felig, P.,
and Bergman, M.
(1995)
in
Endocrinology and Metabolism
(Felig, P.
, Baxter, J. D.
, and Frohman, L. A., eds), 3rd Ed.
, pp. 1107-1250, McGraw-Hill, Inc., New York
|
| 9.
|
Reeds, P. J.,
Fjeld, C. R.,
and Jahoor, F.
(1994)
J. Nutr.
124,
906-910[Free Full Text]
|
| 10.
|
Castillo, C. E.,
Katz, A.,
Spencer, M. K.,
Yan, Z.,
and Nyomba, B. L.
(1991)
Am. J. Physiol.
261,
E598-E605[Abstract/Free Full Text]
|
| 11.
|
Gibala, M. J.,
MacLean, D. A.,
Graham, T. E.,
and Saltin, B.
(1998)
Am. J. Physiol.
275,
E235-E242
|
| 12.
|
Sahlin, K.,
Katz, A.,
and Broberg, S.
(1990)
Am. J. Physiol.
259,
C834-C841[Abstract/Free Full Text]
|
| 13.
|
Garber, A. J.,
Karl, I. E.,
and Kipnis, D. M.
(1976)
J. Biol. Chem.
251,
826-835[Abstract/Free Full Text]
|
| 14.
|
Chang, T. W.,
and Goldberg, A. L.
(1978)
J. Biol. Chem.
253,
3685-3695[Free Full Text]
|
| 15.
|
Matthews, D. E.,
Marano, M. A.,
and Campbell, R. G.
(1993)
Am. J. Physiol.
264,
E848-E854[Abstract/Free Full Text]
|
| 16.
|
Haisch, M.,
Fukagawa, N. K.,
and Matthews, D. E.
(2000)
Am. J. Physiol.
278,
E593-E602[Abstract/Free Full Text]
|
| 17.
|
Devapatla, S.,
Parimi, P.,
O'Brien, A.,
Gruca, L.,
and Kalhan, S.
(2002)
Pediatr. Res.
51,
286A
|
| 18.
|
Elia, M.,
Zed, C.,
Neale, G.,
and Livesey, G.
(1987)
Metabolism
36,
251-255[CrossRef][Medline]
[Order article via Infotrieve]
|
| 19.
|
Miyoshi, H.,
Shulman, G. I.,
Peters, E. J.,
Wolfe, M. H.,
Elahi, D.,
and Wolfe, R. R.
(1988)
J. Clin. Invest.
81,
1545-1555[Medline]
[Order article via Infotrieve]
|
| 20.
|
Patel, D.,
and Kalhan, S.
(1992)
Pediatr. Res.
31,
52-58[Medline]
[Order article via Infotrieve]
|
| 21.
|
Vaughan, M.
(1962)
J. Biol. Chem.
237,
3354-3361[Free Full Text]
|
| 22.
|
Ballard, F. J.,
Hanson, R. W.,
and Leveille, G. A.
(1967)
J. Biol. Chem.
242,
2746-2750[Abstract/Free Full Text]
|
| 23.
|
Reshef, L.,
Hanson, R. W.,
and Ballard, F. J.
(1970)
J. Biol. Chem.
245,
5979-5984[Abstract/Free Full Text]
|
| 24.
|
Botion, L. M.,
Brito, M. N.,
Brito, N. A.,
Brito, S. R.,
Kettelhut, I. C.,
and Migliorini, R. H.
(1998)
Metabolism
47,
1217-1221[CrossRef][Medline]
[Order article via Infotrieve]
|
| 25.
|
Kalhan, S. C.,
Mahajan, S.,
Burkett, E.,
Reshef, L.,
and Hanson, R. W.
(2001)
J. Biol. Chem.
276,
12928-12931[Abstract/Free Full Text]
|
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
W. T. Festuccia, P.-G. Blanchard, V. Turcotte, M. Laplante, M. Sariahmetoglu, D. N. Brindley, D. Richard, and Y. Deshaies
The PPAR{gamma} agonist rosiglitazone enhances rat brown adipose tissue lipogenesis from glucose without altering glucose uptake
Am J Physiol Regulatory Integrative Comp Physiol,
May 1, 2009;
296(5):
R1327 - R1335.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Grafahrend-Belau, F. Schreiber, D. Koschutzki, and B. H. Junker
Flux Balance Analysis of Barley Seeds: A Computational Approach to Study Systemic Properties of Central Metabolism
Plant Physiology,
January 1, 2009;
149(1):
585 - 598.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. K. Nye, R. W. Hanson, and S. C. Kalhan
Glyceroneogenesis Is the Dominant Pathway for Triglyceride Glycerol Synthesis in Vivo in the Rat
J. Biol. Chem.,
October 10, 2008;
283(41):
27565 - 27574.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Noguchi, N. Shikata, Y. Furuhata, T. Kimura, and M. Takahashi
Characterization of dietary protein-dependent amino acid metabolism by linking free amino acids with transcriptional profiles through analysis of correlation
Physiol Genomics,
August 1, 2008;
34(3):
315 - 326.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Guay, S. R. M. Madiraju, A. Aumais, E. Joly, and M. Prentki
A Role for ATP-Citrate Lyase, Malic Enzyme, and Pyruvate/Citrate Cycling in Glucose-induced Insulin Secretion
J. Biol. Chem.,
December 7, 2007;
282(49):
35657 - 35665.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Hakimi, J. Yang, G. Casadesus, D. Massillon, F. Tolentino-Silva, C. K. Nye, M. E. Cabrera, D. R. Hagen, C. B. Utter, Y. Baghdy, et al.
Overexpression of the Cytosolic Form of Phosphoenolpyruvate Carboxykinase (GTP) in Skeletal Muscle Repatterns Energy Metabolism in the Mouse
J. Biol. Chem.,
November 9, 2007;
282(45):
32844 - 32855.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. T. Rodgers and P. Puigserver
Fasting-dependent glucose and lipid metabolic response through hepatic sirtuin 1
PNAS,
July 31, 2007;
104(31):
12861 - 12866.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Lasanthi-Kudahettige, L. Magneschi, E. Loreti, S. Gonzali, F. Licausi, G. Novi, O. Beretta, F. Vitulli, A. Alpi, and P. Perata
Transcript Profiling of the Anoxic Rice Coleoptile
Plant Physiology,
May 1, 2007;
144(1):
218 - 231.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Gershman, O. Puig, L. Hang, R. M. Peitzsch, M. Tatar, and R. S. Garofalo
High-resolution dynamics of the transcriptional response to nutrition in Drosophila: a key role for dFOXO
Physiol Genomics,
March 14, 2007;
29(1):
24 - 34.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Atamna, J. Newberry, R. Erlitzki, C. S. Schultz, and B. N. Ames
Biotin Deficiency Inhibits Heme Synthesis and Impairs Mitochondria in Human Lung Fibroblasts
J. Nutr.,
January 1, 2007;
137(1):
25 - 30.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Xu, W.N. P. Lee, J. Phan, M. F. Saad, K. Reue, and I. J. Kurland
Lipin Deficiency Impairs Diurnal Metabolic Fuel Switching
Diabetes,
December 1, 2006;
55(12):
3429 - 3438.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. M. Kadrofske, P. S. Parimi, L. L. Gruca, and S. C. Kalhan
Effect of intravenous amino acids on glutamine and protein kinetics in low-birth-weight preterm infants during the immediate neonatal period
Am J Physiol Endocrinol Metab,
April 1, 2006;
290(4):
E622 - E630.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Nissim, Y. Daikhin, I. Nissim, B. Luhovyy, O. Horyn, S. L. Wehrli, and M. Yudkoff
Agmatine Stimulates Hepatic Fatty Acid Oxidation: A POSSIBLE MECHANISM FOR UP-REGULATION OF UREAGENESIS
J. Biol. Chem.,
March 31, 2006;
281(13):
8486 - 8496.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Solinas, S. Summermatter, D. Mainieri, M. Gubler, J. P. Montani, J. Seydoux, S. R. Smith, and A. G. Dulloo
Corticotropin-Releasing Hormone Directly Stimulates Thermogenesis in Skeletal Muscle Possibly through Substrate Cycling between de Novo Lipogenesis and Lipid Oxidation
Endocrinology,
January 1, 2006;
147(1):
31 - 38.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Vankoningsloo, M. Piens, C. Lecocq, A. Gilson, A. De Pauw, P. Renard, C. Demazy, A. Houbion, M. Raes, and T. Arnould
Mitochondrial dysfunction induces triglyceride accumulation in 3T3-L1 cells: role of fatty acid {beta}-oxidation and glucose
J. Lipid Res.,
June 1, 2005;
46(6):
1133 - 1149.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. C. Burgess, N. Hausler, M. Merritt, F. M. H. Jeffrey, C. Storey, A. Milde, S. Koshy, J. Lindner, M. A. Magnuson, C. R. Malloy, et al.
Impaired Tricarboxylic Acid Cycle Activity in Mouse Livers Lacking Cytosolic Phosphoenolpyruvate Carboxykinase
J. Biol. Chem.,
November 19, 2004;
279(47):
48941 - 48949.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. O. Lambeth, K. N. Tews, S. Adkins, D. Frohlich, and B. I. Milavetz
Expression of Two Succinyl-CoA Synthetases with Different Nucleotide Specificities in Mammalian Tissues
J. Biol. Chem.,
August 27, 2004;
279(35):
36621 - 36624.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Fukuda, T. Fukui, H. Atomi, and T. Imanaka
First Characterization of an Archaeal GTP-Dependent Phosphoenolpyruvate Carboxykinase from the Hyperthermophilic Archaeon Thermococcus kodakaraensis KOD1
J. Bacteriol.,
July 15, 2004;
186(14):
4620 - 4627.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Wei, W. Shen, M. Dauk, F. Wang, G. Selvaraj, and J. Zou
Targeted Gene Disruption of Glycerol-3-phosphate Dehydrogenase in Colletotrichum gloeosporioides Reveals Evidence That Glycerol Is a Significant Transferred Nutrient from Host Plant to Fungal Pathogen
J. Biol. Chem.,
January 2, 2004;
279(1):
429 - 435.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. J. MacDonald, L. A. Fahien, J. D. Buss, N. M. Hasan, M. J. Fallon, and M. A. Kendrick
Citrate Oscillates in Liver and Pancreatic Beta Cell Mitochondria and in INS-1 Insulinoma Cells
J. Biol. Chem.,
December 19, 2003;
278(51):
51894 - 51900.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Stepansky and G. Galili
Synthesis of the Arabidopsis Bifunctional Lysine-Ketoglutarate Reductase/Saccharopine Dehydrogenase Enzyme of Lysine Catabolism Is Concertedly Regulated by Metabolic and Stress-Associated Signals
Plant Physiology,
November 1, 2003;
133(3):
1407 - 1415.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. E. Reszko, T. Kasumov, B. A. Pierce, F. David, C. L. Hoppel, W. C. Stanley, C. Des Rosiers, and H. Brunengraber
Assessing the Reversibility of the Anaplerotic Reactions of the Propionyl-CoA Pathway in Heart and Liver
J. Biol. Chem.,
September 12, 2003;
278(37):
34959 - 34965.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Wilson-Fritch, A. Burkart, G. Bell, K. Mendelson, J. Leszyk, S. Nicoloro, M. Czech, and S. Corvera
Mitochondrial Biogenesis and Remodeling during Adipogenesis and in Response to the Insulin Sensitizer Rosiglitazone
Mol. Cell. Biol.,
February 1, 2003;
23(3):
1085 - 1094.
[Abstract]
[Full Text]
|
 |
|
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|